Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Organigram Global Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of OGI: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders111186−24
Shares25.5M7.35M15.7M−2.48M (−13.6%)
Value$16.5M$4.71M$6.05M−$5.72M (−48.6%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Organigram Global Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to OGI in Q2 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC525,602$198.5K0.00%
Flow Traders U.S. LLC42,786$17.0K0.00%
Cubist Systematic Strategies, LLC27,712$10.8K0.00%
First Affirmative Financial Network19,224$7.50K0.01%
Creative Planning15,623$6.09K0.00%
Atria Wealth Solutions, Inc.12,500$4.72K0.00%
HRT Financial LP12,302$4.00K0.00%
Baader Bank INC12,447$2.75K0.00%
Tyler-Stone Wealth Management4,000$2.00K0.00%
Fiduciary Alliance LLC140$550.00%
JPMorgan Chase & Co18,372––
Meitav Dash Investments Ltd322––

Sold out (36)

Institutions that held Organigram Global Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held Organigram Global Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
ETF Managers Group, LLC7,353,933$4.71M